IPG Photonics is navigating a cyclical recovery with three consecutive quarters of revenue growth, reaching $278.6M in Q2 2026 (up 11.1% YoY), yet structural margin compression from Chinese competition keeps operating margins at a razor-thin 1.6%. The company'...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 4, 2026 | $0.12-67.2% vs $0.37 | $279M-0.5% vs $280M |
Q2 2026 May 5, 2026 | $0.04-87.5% vs $0.32 | $265M+3.3% vs $257M |
Q1 2026 Feb 12, 2026 | $0.46+84.0% vs $0.25 | $274M+10.0% vs $250M |
Q4 2025 Nov 4, 2025 | $0.18+12.5% vs $0.16 | $251M+4.6% vs $240M |
I initiate coverage on IPG Photonics with a 'Buy' rating, citing a compelling business mix transition. IPGP's acquisition of Lumibird Medical boosts exposure to the medical end -market, boasting a superior financial profile than its legacy operations. The company is shifting organically toward promising business areas like AI, defense, and medical.
IPG Photonics (NASDAQ: IPGP - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Profitability This table compares IPG Photonics and 908
IPG (IPGP) reported earnings 30 days ago. What's next for the stock?
Evaluate IPG's (IPGP) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Benchmark IPGP against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for IPG Photonics Corporation (IPGP)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $78.20 | $3.32B | 107.12 | 2.73% | 3.1% | 1.5% | — | |
| $945.67 | $73.57B | 2555.86 | 21.03% | -230.1% | -300.07% | — | |
| $11.74 | $991.41M | 27.95 | 27.38% | 12.9% | 10.96% | — | |
| $260.37 | $17.59B | 59.58 | 9.62% | 10.12% | 15.83% | — | |
| $144.17 | $5.13B | 98.07 | 3.3% | 6% | 4.9% | — | |
| $36.40 | $8.98B | 242.67 | 8.39% | -2% | -3.16% | — |
IPG Photonics Corporation (IPGP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
IPG Photonics Corporation (IPGP) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
Jul 17, 2026·SEC
May 15, 2026·SEC
Get notified when IPGP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
IPG Photonics Corporation (IPGP) stock FAQ — growth, dividends, profitability & financials explained
IPG Photonics Corporation (IPGP) reported $1.07B in revenue for fiscal year 2025. This represents a 1661% increase from $60.7M in 2004.
IPG Photonics Corporation (IPGP) grew revenue by 2.7% over the past year. Growth has been modest.
Yes, IPG Photonics Corporation (IPGP) is profitable, generating $27.6M in net income for fiscal year 2025 (3.1% net margin).
IPG Photonics Corporation (IPGP) has a return on equity (ROE) of 1.5%. This is below average, suggesting room for improvement.
IPG Photonics Corporation (IPGP) generated $20.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
